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Recently, Springer published two medicinal plant books, 'Herbal Drugs: Ethnomedicine to Modern Medicine', edited by K.G. Ramawat, and 'Bioactive Molecules and Medicinal Plants', edited by K.G. Ramawat and J.M. Merillon. Both books consider the above-mentioned issues using a chemical and molecular biology-oriented approach towards the assessment of potential activities of traditionally used medicinal plants and the efficient and renewable sourcing of their bioactive principles using biotechnology.

Reflecting current trends in the life sciences, most of the plant-derived pharmaceuticals dealt with in both books refer to conditions directly or implicitly involving inflammatory signaling and apoptosis (e.g., cancer, the immune system, and neuronal protection). These two informative books complement each other. Their layouts are very similar, clearly sub-structured, supported with skeletal formulas, and illustrated mainly with black and white photographs, schemes, tables, and graphs.

The following reviews outline the approach adopted by each book for their suggested audiences. As the books complement each other, potential readers would be advised to consult the table of contents to see which book best fits their needs. These can be downloaded from the Springer webpages:

<http://www.springer.com/chemistry/book/978-3-540-79115-7> and

<http://www.springer.com/chemistry/biotech/book/978-3-540-74600-3>.

Bioactive Molecules and Medicinal Plants {#Sec1}
========================================

Demand for medicinal plants is on the rise and, as a result, the need for sustainable agricultural production systems for these is becoming increasingly important. According to the World Health Organization, one of the key challenges for the future of herbal medicine is 'to preserve both plant populations and knowledge on how to use them for medicinal purposes'. For an expanding population in poor countries, their local, traditional plant medicine is the only choice of treatment, whereas in developed countries, herbal products have become increasingly popular and commercially profitable.

'Bioactive Molecules and Medicinal Plants' focusses on the biotechnological production of certain sought-after secondary plant metabolites. It is a compilation of 20 practically oriented articles that will be most useful for all interested in biotechnology and agricultural sciences, and in particular, researchers dealing with pharmacognosy or ethnobotany. Two stimulating general chapters that would also appeal to a less specialised audience inform the reader of the history of medicinal plants and recent developments.

The question of whether natural production can meet the demand is a central one. Many chapters deal directly or indirectly with the impact of environmental factors, e.g. age of the plant, harvesting time and location and on the quantity and quality of the required compounds. 'Bioactive Molecules and Medicinal Plants' suggests biotechnological methods such as plant cell culture of genetically modified species for a sufficient yield of the desired molecules, especially for precious alkaloids with a complicated structure and therefore inefficient chemical synthesis.

\[One technology reviewed in this book is Hairy Roots, a symptom of a bacterial infection integrating genes into a plant host. Transgenic root systems are versatile, not only as a biological study model of metabolic pathways, but also they can be used for the industrial scale production of recombinant animal proteins and plant secondary metabolites.\]

Finally, with natural products comes the need for research into safety and standardisation. This is covered by a chapter on standardisation methods and efficacy and safety of phytomedicins, of particular interest for the pharmaceutical technologist.

Herbal Drugs: Ethnomedicine to Modern Medicine {#Sec2}
==============================================

Herbal Drugs: Ethnomedicine to Modern Medicine' presents pharmacological profiles for selected medicinal plants. Whilst emphasising the elucidation of molecular action mechanisms, it also considers historical aspects, facts around the drug's use, plus social and clinical implications. Among the topics are circulatory diseases including stroke, memory enhancement, neuronal protection, sexual malfunctions, immunological disorders, cancer and parasitology.

The introductory chapters are overviews of traditional medicinal plant knowledge and subsequent drug identification as well as general principles of the biosynthesis and chemical diversity of secondary metabolites.

Several chapters review generally observed data concerning the use of medicinal plants (e.g. safety in paediatrics and pregnancy, plants used for drug abuse, safety in cancer prevention and treatment) or deal with the description of ill-reported systems of traditional medicine (Ethnobotanical Study from Rajasthan).

Whilst some readers might find the article on a suggested 'nutriceutical', a vitamin E analogue to 'Golden Rice', controversial, the majority of articles in 'Herbal Drugs: Ethnomedicine to Modern Medicine' are highly informative and excellently written by medicinal plant experts not only for researchers but also a wide range of health professionals and pharmacognosy students.
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Researchers at Berkeley are building towards a future where specific human tissue could be engineered using a process akin to organic synthesis. This 'bottom-up strategy' was used to couple cells together using simple complementary small molecules, in this case DNA oligonucleotides.

Jurkat cells were dyed fluorescently and then labelled metabolically to provide azido sialic acid moieties on the cell surface, which could then be coupled to single stranded DNA using click chemistry. Two sets of cells with complementary sequences, when mixed, were able to form large aggregates. As in a chemical reaction, controlling the stoichiometry of the reacting cells allowed the formation of the desired product, in this case a smaller, organised cell cluster. Usefully, FACS sorting was employed to purify the desired cell clusters away from the undesired, using the fluorescence properties of the fluorescently labelled cells.

The DNA linkages used to hold the cells together were reversible in nature. The application of heat (to surpass the melting temperature of the complimentary DNA) or addition of DNAse disrupted the cells from binding to each other. This could prove useful for templating experiments.

This method was also applied to create a tissue with a functional hormonal signalling network where one group of cells expressed growth factor interleukin-3 and another was an untransformed hematopoietic progenitor cell line. When the DNA-labelled cells were mixed and coupled using the described chemistry, the progenitor cells underwent growth after 16 h. In comparison uncoupled cells, which were allowed to randomly mix, entered apoptosis.

Not only could this method be used for the building of human tissues, but also for the study of tissue architecture and function.
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